$18.51
0.663.70%
At close: -
$18.93
0.422.27%
After Hours: 7:54 PM EDT
Comments
Loading...
Alignment Healthcare Stock Guidance | NASDAQ:ALHC | Benzinga
Alignment Healthcare issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/27/2025 | ALHC | Alignment Healthcare | Q1 | 2025 | — | — | — | $880.00M | $895.00M | $854.69M | Get Alert |
| 02/27/2025 | ALHC | Alignment Healthcare | FY | 2025 | — | — | — | $3.72B | $3.77B | $3.48B | Get Alert |
| 10/29/2024 | ALHC | Alignment Healthcare | FY | 2024 | — | — | — | $2.67B | $2.68B | $2.63B | Get Alert |
| 10/29/2024 | ALHC | Alignment Healthcare | Q4 | 2024 | — | — | — | $663.00M | $678.00M | $660.89M | Get Alert |
| 08/01/2024 | ALHC | Alignment Healthcare | FY | 2024 | — | — | — | $2.61B | $2.64B | $2.52B | Get Alert |
| 08/01/2024 | ALHC | Alignment Healthcare | Q3 | 2024 | — | — | — | $655.00M | $665.00M | $630.25M | Get Alert |
| 05/02/2024 | ALHC | Alignment Healthcare | FY | 2024 | — | — | — | $2.50B | $2.52B | $2.41B | Get Alert |
| 05/02/2024 | ALHC | Alignment Healthcare | Q2 | 2024 | — | — | — | $625.00M | $635.00M | $608.65M | Get Alert |
| 02/27/2024 | ALHC | Alignment Healthcare | FY | 2024 | — | — | — | $2.38B | $2.41B | $2.29B | Get Alert |
| 02/27/2024 | ALHC | Alignment Healthcare | Q1 | 2024 | — | — | — | $590.00M | $600.00M | $550.79M | Get Alert |
| 11/02/2023 | ALHC | Alignment Healthcare | FY | 2023 | — | — | — | $1.78B | $1.80B | $1.78B | Get Alert |
| 11/02/2023 | ALHC | Alignment Healthcare | Q4 | 2023 | — | — | — | $422.00M | $442.00M | $434.86M | Get Alert |
| 08/03/2023 | ALHC | Alignment Healthcare | FY | 2023 | — | — | — | $1.76B | $1.78B | $1.74B | Get Alert |
| 08/03/2023 | ALHC | Alignment Healthcare | Q3 | 2023 | — | — | — | $440.00M | $445.00M | $428.29M | Get Alert |
| 05/04/2023 | ALHC | Alignment Healthcare | Q2 | 2023 | — | — | — | $433.00M | $438.00M | $431.37M | Get Alert |
| 05/04/2023 | ALHC | Alignment Healthcare | FY | 2023 | — | — | — | $1.71B | $1.74B | $1.73B | Get Alert |
| 02/28/2023 | ALHC | Alignment Healthcare | FY | 2023 | — | — | — | $1.71B | $1.73B | $1.70B | Get Alert |
| 02/28/2023 | ALHC | Alignment Healthcare | Q1 | 2023 | — | — | — | $429.00M | $434.00M | $420.54M | Get Alert |
| 11/03/2022 | ALHC | Alignment Healthcare | FY | 2022 | — | — | — | $1.41B | $1.42B | $1.38B | Get Alert |
| 11/03/2022 | ALHC | Alignment Healthcare | Q4 | 2022 | — | — | — | $338.00M | $343.00M | $330.18M | Get Alert |
| 08/04/2022 | ALHC | Alignment Healthcare | FY | 2022 | — | — | — | $1.36B | $1.38B | $1.35B | Get Alert |
| 08/04/2022 | ALHC | Alignment Healthcare | Q3 | 2022 | — | — | — | $330.00M | $335.00M | $331.14M | Get Alert |
| 05/05/2022 | ALHC | Alignment Healthcare | FY | 2022 | — | — | — | $1.33B | $1.35B | $1.34B | Get Alert |
| 05/05/2022 | ALHC | Alignment Healthcare | Q2 | 2022 | — | — | — | $335.00M | $340.00M | $339.68M | Get Alert |
| 03/03/2022 | ALHC | Alignment Healthcare | Q1 | 2022 | — | — | — | $330.00M | $335.00M | $316.24M | Get Alert |
| 03/03/2022 | ALHC | Alignment Healthcare | FY | 2022 | — | — | — | $1.33B | $1.34B | $1.34B | Get Alert |
| 11/04/2021 | ALHC | Alignment Healthcare | Q4 | 2021 | — | — | — | $265.00M | $270.00M | $269.44M | Get Alert |
| 11/04/2021 | ALHC | Alignment Healthcare | FY | 2021 | — | — | — | $1.14B | $1.14B | $1.13B | Get Alert |
| 08/09/2021 | ALHC | Alignment Healthcare | Q3 | 2021 | — | — | — | $270.00M | $275.00M | $259.80M | Get Alert |
| 08/09/2021 | ALHC | Alignment Healthcare | FY | 2021 | — | — | — | $1.10B | $1.12B | $1.06B | Get Alert |
| 05/17/2021 | ALHC | Alignment Healthcare | Q2 | 2021 | — | — | — | $265.00M | $270.00M | $248.69M | Get Alert |
| 05/17/2021 | ALHC | Alignment Healthcare | FY | 2021 | — | — | — | $1.04B | $1.05B | $1.00B | Get Alert |
FAQ
What is the most recent guidance for Alignment Healthcare (ALHC)?
There have been no specific sales or earnings guidance reported for Alignment Healthcare in recent months.
Browse guidance and forecast on all stocks.